LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway

Yilan Wu1, Han Wang2

  • 1School of Nursing, Fujian University of Traditional Chinese Medicine, Fujian 350122, People's Republic of China.

Insights

Dexamethasone resistance in multiple myeloma is a poor prognostic indicator. This study found that targeting NEAT1 can restore myeloma cell sensitivity to dexamethasone, offering a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Dexamethasone (DEX) is a primary treatment for multiple myeloma (MM).
  • DEX resistance in MM correlates with poor patient outcomes.
  • Developing strategies to overcome DEX resistance is crucial for MM treatment.

Purpose of the Study:

  • To investigate the role of long non-coding RNA NEAT1 in DEX resistance in MM.
  • To elucidate the molecular mechanisms underlying DEX resistance involving NEAT1.

Main Methods:

  • Analysis of NEAT1 expression in DEX-resistant MM cell lines.
  • Investigating the relationship between NEAT1, miR-193a, and MCL1 expression.
  • Assessing the impact of NEAT1 knockdown and overexpression on DEX sensitivity.

Main Results:

  • NEAT1 was highly expressed in DEX-resistant MM cells and linked to poor prognosis.
  • Decreased miR-193a levels and increased MCL1 expression were observed during DEX resistance development.
  • NEAT1 knockdown enhanced DEX sensitivity in resistant cells, while overexpression induced resistance in sensitive cells.

Conclusions:

  • The NEAT1/miR-193a/MCL1 pathway is implicated in the development of DEX resistance in MM.
  • Targeting NEAT1 presents a potential strategy to improve DEX sensitivity in MM patients.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.1K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.3K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K